Zepure Kouyoumdjian, DO
Neurology · Napa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 29
- 7 carriers
- Office
- 1
Offices
1 location · Bass Medical Group · 292 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
29 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Kouyoumdjian’s office at (707) 287-2513 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
29 of 29 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$768,290
Medicare paid this office $768,290 for 784 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Botox | 92 | $280,636 | None |
| Measurement of brain wave activity (eeg), awake and asleep | 334 | $165,791 | $492 |
| Measurement of brain wave activity (eeg), 12-26 hours | 67 | $59,639 | $317 |
| Muscle electrical test | 210 | $48,954 | $99 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 91 | $40,189 | $142 |
See all 17 services
| Botox | 92 | $280,636 | None |
| Measurement of brain wave activity (eeg), awake and asleep | 334 | $165,791 | $492 |
| Measurement of brain wave activity (eeg), 12-26 hours | 67 | $59,639 | $317 |
| Muscle electrical test | 210 | $48,954 | $99 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 91 | $40,189 | $142 |
| Nerve test | 115 | $32,000 | $276 |
| Return visit (30+ min) | 226 | $30,977 | $112 |
| Short return visit (20+ min) | 152 | $26,095 | $86 |
| Nerve test | 96 | $20,563 | $214 |
| Measurement of brain wave activity (eeg), continuous | 68 | $19,059 | $280 |
| Measurement of brain wave activity (eeg), 61-84 hours with health care professional review and report | 60 | $14,023 | $230 |
| Nerve test | 35 | $8,423 | $241 |
| New patient visit (45+ min) | 41 | $6,187 | $151 |
| Long return visit (40+ min) | 30 | $4,947 | $165 |
| New patient visit (60+ min) | 13 | $2,486 | $191 |
| Exam of neurobehavioral status, first hour | 22 | $1,749 | $79 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 56 | $830 | $15 |
Who their Medicare patients are
784 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 13% · Women 63% · Also on Medicaid 3% · Health risk score 1.16. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 74% · Coronary heart disease 30% · Depression 28% · Diabetes 25% · Stroke 22% · Chronic kidney disease 20% · Dementia 19% · Atrial fibrillation 17% · Heart failure 13% · Cancer 13% · COPD 11%.
The office billed $2,997,447, Medicare allowed $978,955 and paid $768,290; for 59,706 services of 32 kinds; $280,664 of it was for drugs given in the office and $487,626 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 784 | 59,706 | 75 | 1.16 | $2,997,447 | $768,290 |
| 2023 | 769 | 56,731 | 76 | 1.12 | $2,356,542 | $674,479 |
| 2022 | 832 | 55,561 | 76 | 1.15 | $2,279,938 | $657,518 |
| 2021 | 834 | 44,329 | 76 | 1.09 | $2,083,130 | $613,088 |
| 2020 | 725 | 29,795 | 75 | 1.21 | $1,758,518 | $487,903 |
| 2019 | 697 | 19,329 | 75 | 1.18 | $1,642,606 | $479,786 |
| 2018 | 644 | 16,315 | 75 | 1.24 | $1,816,759 | $521,389 |
| 2017 | 717 | 14,083 | 74 | 1.38 | $1,768,413 | $489,099 |
| 2016 | 728 | 12,042 | 73 | 1.41 | $1,937,655 | $571,507 |
| 2015 | 782 | 10,854 | 74 | 1.39 | $1,937,950 | $624,795 |
| 2014 | 819 | 6,217 | 73 | 1.33 | $1,779,020 | $550,443 |
| 2013 | 689 | 4,589 | 73 | 1.41 | $928,905 | $526,099 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Botox | 91 | $265,542 | None |
| Measurement of brain wave activity (eeg), awake and asleep | 265 | $124,581 | $463 |
| Muscle electrical test | 238 | $57,581 | $101 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 88 | $38,357 | $144 |
| Nerve test | 118 | $34,379 | $284 |
| Return visit (30+ min) | 231 | $34,234 | $109 |
| Short return visit (20+ min) | 182 | $26,470 | $83 |
| Nerve test | 105 | $26,107 | $249 |
| Measurement of brain wave activity (eeg), 12-26 hours | 25 | $22,279 | $323 |
| Nerve test | 61 | $12,907 | $212 |
| Measurement of brain wave activity (eeg), continuous | 26 | $7,463 | $287 |
| New patient visit (45+ min) | 40 | $6,120 | $153 |
| Long return visit (40+ min) | 26 | $4,556 | $163 |
| Measurement of brain wave activity (eeg), 61-84 hours with health care professional review and report | 18 | $4,265 | $237 |
| New patient visit (60+ min) | 14 | $2,965 | $212 |
| Testing of autonomic (sympathetic) nervous system function | 11 | $1,452 | $132 |
2022: 20 services
| Botox | 87 | $254,081 | None |
| Measurement of brain wave activity (eeg), awake and asleep | 261 | $114,280 | $433 |
| Muscle electrical test | 251 | $60,273 | $102 |
| Return visit (30+ min) | 288 | $43,725 | $112 |
| Nerve test | 145 | $42,422 | $283 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 85 | $36,621 | $143 |
| Short return visit (20+ min) | 200 | $25,018 | $79 |
| Nerve test | 75 | $17,817 | $238 |
| Nerve test | 73 | $15,886 | $218 |
| Measurement of brain wave activity (eeg), 12-26 hours | 18 | $14,891 | $317 |
| New patient visit (45+ min) | 56 | $7,917 | $141 |
| Long return visit (40+ min) | 31 | $6,148 | $166 |
| Measurement of brain wave activity (eeg), continuous | 18 | $5,089 | $283 |
| Exam of neurobehavioral status, first hour | 35 | $2,743 | $78 |
| New patient visit (60+ min) | 15 | $2,716 | $181 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 40 | $1,897 | $35 |
| Testing of autonomic (sympathetic) nervous system function | 13 | $1,503 | $116 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 36 | $912 | $18 |
| Injection of drug or substance under skin or into muscle | 16 | $583 | $13 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 16 | $56 | None |
2021: 17 services
| Botox | 74 | $198,029 | None |
| Measurement of brain wave activity (eeg), awake and asleep | 254 | $113,978 | $443 |
| Muscle electrical test | 241 | $63,174 | $108 |
| Return visit (30+ min) | 333 | $50,811 | $108 |
| Nerve test | 142 | $43,711 | $308 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 71 | $29,375 | $145 |
| Short return visit (20+ min) | 251 | $28,340 | $81 |
| Nerve test | 103 | $27,645 | $268 |
| Measurement of brain wave activity (eeg), 12-26 hours | 13 | $12,065 | $326 |
| New patient visit (45+ min) | 72 | $11,139 | $155 |
| Nerve test | 48 | $11,115 | $232 |
| Long return visit (40+ min) | 33 | $5,836 | $167 |
| Measurement of brain wave activity (eeg), continuous | 14 | $4,058 | $290 |
| Exam of neurobehavioral status, first hour | 39 | $3,476 | $89 |
| Testing of autonomic (sympathetic) nervous system function | 23 | $2,917 | $127 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 14 | $671 | $35 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 13 | $487 | $27 |
2020: 16 services
| Botox | 55 | $130,713 | None |
| Measurement of brain wave activity (eeg), awake and asleep | 196 | $87,911 | $449 |
| Return visit (30+ min) | 516 | $76,878 | $93 |
| Nerve test | 90 | $29,258 | $308 |
| Muscle electrical test | 120 | $28,229 | $102 |
| Long return visit (40+ min) | 152 | $20,973 | $117 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 54 | $18,906 | $140 |
| New patient visit (60+ min) | 99 | $18,726 | $185 |
| New patient visit (45+ min) | 104 | $16,165 | $148 |
| Measurement of brain wave activity (eeg), 12-26 hours | 17 | $15,144 | $316 |
| Exam of neurobehavioral status, first hour | 103 | $9,394 | $91 |
| Short return visit (20+ min) | 82 | $6,505 | $63 |
| Nerve test | 27 | $6,375 | $236 |
| Measurement of brain wave activity (eeg), continuous | 20 | $5,592 | $280 |
| Nerve test | 17 | $4,568 | $269 |
| Testing of autonomic (sympathetic) nervous system function | 27 | $3,340 | $124 |
2019: 18 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 15 | $87,478 | $1,944 |
| Botox | 28 | $80,470 | None |
| Measurement of brain wave activity (eeg), awake and asleep | 159 | $71,124 | $447 |
| Return visit (30+ min) | 405 | $56,970 | $93 |
| Long return visit (40+ min) | 278 | $47,053 | $122 |
| New patient visit (60+ min) | 184 | $32,209 | $175 |
| Muscle electrical test | 101 | $20,697 | $94 |
| Nerve test | 60 | $18,117 | $288 |
| Exam of neurobehavioral status, first hour | 167 | $14,533 | $87 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 28 | $11,263 | $134 |
| New patient visit (45+ min) | 76 | $10,709 | $141 |
| Nerve test | 44 | $10,496 | $233 |
| Testing of autonomic (sympathetic) nervous system function | 34 | $4,321 | $127 |
| Short return visit (20+ min) | 29 | $2,886 | $67 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 15 | $2,804 | $38 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 15 | $2,465 | $85 |
| Injection of drug or substance under skin or into muscle | 11 | $456 | $16 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 11 | $40 | None |
2018: 18 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 29 | $158,014 | $1,859 |
| Measurement of brain wave activity (eeg), awake and asleep | 160 | $69,474 | $429 |
| Botox | 21 | $64,292 | None |
| Long return visit (40+ min) | 334 | $62,062 | $118 |
| Return visit (30+ min) | 325 | $40,345 | $87 |
| New patient visit (60+ min) | 207 | $35,679 | $172 |
| Exam of neurobehavioral status, first hour | 187 | $15,644 | $81 |
| Muscle electrical test | 77 | $13,577 | $86 |
| Nerve test | 41 | $11,496 | $280 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 21 | $8,465 | $121 |
| Nerve test | 35 | $7,871 | $225 |
| Measurement of brain wave activity (eeg), digital analysis | 24 | $7,111 | $284 |
| Testing of autonomic (sympathetic) nervous system function | 52 | $6,562 | $126 |
| New patient visit (45+ min) | 35 | $4,906 | $140 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 29 | $4,648 | $82 |
| Short return visit (20+ min) | 24 | $2,624 | $61 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 22 | $2,350 | $34 |
| Test for balance and posture | 22 | $2,184 | $99 |
2017: 18 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 24 | $128,842 | $1,815 |
| Measurement of brain wave activity (eeg), awake and asleep | 190 | $78,856 | $415 |
| Return visit (30+ min) | 471 | $62,091 | $84 |
| Botox | 22 | $53,121 | None |
| Long return visit (40+ min) | 276 | $44,145 | $127 |
| New patient visit (60+ min) | 139 | $24,048 | $173 |
| Exam of neurobehavioral status, first hour | 205 | $15,978 | $77 |
| Nerve test | 49 | $13,622 | $278 |
| Muscle electrical test | 74 | $13,354 | $87 |
| New patient visit (45+ min) | 82 | $10,360 | $126 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 22 | $6,740 | $114 |
| Measurement of brain wave activity (eeg), digital analysis | 21 | $6,230 | $297 |
| Nerve test | 29 | $6,165 | $213 |
| Short return visit (20+ min) | 67 | $5,286 | $57 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 45 | $4,171 | $37 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 24 | $4,025 | $82 |
| Testing of autonomic (sympathetic) nervous system function | 27 | $3,637 | $135 |
| Neuropsychological testing by a computer with interpretation and report by a qualified healthcare professional | 19 | $908 | $45 |
2016: 18 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 34 | $191,628 | $1,897 |
| Measurement of brain wave activity (eeg), awake and asleep | 213 | $91,363 | $427 |
| Return visit (30+ min) | 522 | $81,925 | $89 |
| Botox | 21 | $41,359 | None |
| New patient visit (60+ min) | 152 | $26,926 | $177 |
| Exam of neurobehavioral status, first hour | 193 | $15,783 | $81 |
| Muscle electrical test | 81 | $15,425 | $89 |
| New patient visit (45+ min) | 103 | $13,810 | $134 |
| Long return visit (40+ min) | 98 | $13,680 | $127 |
| Nerve test | 45 | $12,504 | $278 |
| Testing of autonomic (sympathetic) nervous system function | 71 | $11,862 | $167 |
| Short return visit (20+ min) | 150 | $11,688 | $59 |
| Measurement of brain wave activity (eeg), digital analysis | 28 | $8,935 | $319 |
| Nerve test | 36 | $8,036 | $223 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 22 | $5,826 | $119 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 34 | $5,631 | $85 |
| Test for balance and posture | 47 | $4,928 | $105 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 23 | $2,370 | $38 |
2015: 19 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 41 | $223,170 | $1,875 |
| Measurement of brain wave activity (eeg), awake and asleep | 246 | $104,400 | $419 |
| Return visit (30+ min) | 503 | $74,424 | $93 |
| New patient visit (60+ min) | 218 | $38,901 | $178 |
| Botox | 16 | $34,964 | None |
| Long return visit (40+ min) | 201 | $31,949 | $124 |
| Exam of neurobehavioral status, first hour | 212 | $17,596 | $82 |
| New patient visit (45+ min) | 110 | $15,810 | $144 |
| Muscle electrical test | 72 | $13,319 | $90 |
| Measurement of brain wave activity (eeg), digital analysis | 41 | $12,834 | $313 |
| Nerve test | 41 | $11,567 | $282 |
| Short return visit (20+ min) | 123 | $9,549 | $63 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 41 | $6,734 | $85 |
| Nerve test | 24 | $5,343 | $214 |
| Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | 16 | $4,878 | $125 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 25 | $4,525 | $181 |
| Test for balance and posture | 39 | $4,104 | $105 |
| Evaluation and testing for balance with recording | 39 | $3,755 | $96 |
| Assessment and recording of balance system during irrigation of both ears | 38 | $2,396 | $16 |
2014: 20 services
| Measurement of brain wave activity (eeg), awake and asleep | 297 | $122,535 | $411 |
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 21 | $116,584 | $1,880 |
| Return visit (30+ min) | 433 | $60,996 | $94 |
| New patient visit (60+ min) | 235 | $41,599 | $177 |
| Long return visit (40+ min) | 259 | $38,946 | $116 |
| Muscle electrical test | 112 | $20,603 | $87 |
| New patient visit (45+ min) | 146 | $20,542 | $141 |
| Exam of neurobehavioral status, first hour | 203 | $17,303 | $84 |
| Nerve test | 57 | $16,188 | $284 |
| Short return visit (20+ min) | 191 | $15,592 | $66 |
| Nerve test | 59 | $12,560 | $213 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 63 | $11,440 | $176 |
| Measurement of brain wave activity (eeg), digital analysis | 22 | $9,872 | $449 |
| Test for balance and posture | 84 | $9,322 | $106 |
| Evaluation and testing for balance with recording | 62 | $5,931 | $96 |
| Assessment and recording of balance system during irrigation of both ears | 61 | $3,810 | $16 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 22 | $3,739 | $85 |
| Injection of drug or substance under skin or into muscle | 15 | $1,096 | $25 |
| Measurement of brain wave activity (eeg), awake and asleep | 14 | $731 | $52 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 14 | $76 | None |
2013: 14 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 25 | $127,351 | $1,819 |
| Measurement of brain wave activity (eeg), awake and asleep | 242 | $119,870 | $489 |
| Long return visit (40+ min) | 443 | $103,207 | $128 |
| New patient visit (60+ min) | 279 | $50,349 | $180 |
| Return visit (30+ min) | 168 | $18,887 | $97 |
| Muscle electrical test | 106 | $18,755 | $83 |
| Nerve test | 57 | $16,367 | $287 |
| New patient visit (45+ min) | 88 | $12,630 | $144 |
| Nerve test | 53 | $11,193 | $211 |
| Exam of neurobehavioral status, first hour | 141 | $11,062 | $78 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 60 | $10,829 | $175 |
| Measurement of brain wave activity (eeg), digital analysis | 16 | $7,563 | $473 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 25 | $4,010 | $87 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 15 | $752 | $50 |
Drugs they prescribed that Part D paid
$591,954
Pharmacies billed $591,954 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (25 of 2,162) in 2024. Above the middle of the specialty; the typical neurology clinician is at 0%.
1,793 generic and fewer than 11 brand-name prescriptions · $591,954 in drug cost · 27 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Nuedexta | None | 52 | $84,627 | $1,627 |
| Aimovig | Migraine | 60 | $62,469 | $1,041 |
| Nurtec Odt | None | 26 | $39,125 | $1,505 |
| Ajovy | None | 41 | $37,630 | $918 |
| Ubrelvy | None | 33 | $36,704 | $1,112 |
See all 45 drugs
| Nuedexta | None | 52 | $84,627 | $1,627 |
| Aimovig | Migraine | 60 | $62,469 | $1,041 |
| Nurtec Odt | None | 26 | $39,125 | $1,505 |
| Ajovy | None | 41 | $37,630 | $918 |
| Ubrelvy | None | 33 | $36,704 | $1,112 |
| Ajovy | None | 33 | $23,521 | $713 |
| Emgality | Migraine | 29 | $20,138 | $694 |
| Neupro | None | 17 | $19,346 | $1,138 |
| Emgality | Migraine | 25 | $16,447 | $658 |
| Rivastigmine | None | 33 | $9,035 | $274 |
| Rivastigmine | None | 79 | $8,773 | $111 |
| Rasagiline Mesylate | None | 12 | $8,120 | $677 |
| Memantine | None | 105 | $3,575 | $34 |
| Gabapentin | None | 135 | $2,745 | $20 |
| Pregabalin | None | 110 | $2,595 | $24 |
| Donepezil | None | 163 | $1,566 | $10 |
| Nortriptyline | None | 54 | $1,548 | $29 |
| Topiramate | None | 96 | $1,540 | $16 |
| Amitriptyline | None | 71 | $1,473 | $21 |
| Duloxetine | None | 52 | $1,398 | $27 |
| Levetiracetam | None | 59 | $1,253 | $21 |
| Carbidopa-Levodopa Er | None | 19 | $1,221 | $64 |
| Dextroamphetamine-Amphetamine | None | 24 | $1,142 | $48 |
| Carbidopa-Levodopa | None | 22 | $1,072 | $49 |
| Lacosamide | None | 18 | $1,050 | $58 |
| Rizatriptan | None | 50 | $956 | $19 |
| Clopidogrel | None | 32 | $670 | $21 |
| Sumatriptan | None | 64 | $602 | $9 |
| Dextroamphetamine-Amphet Er | None | 11 | $573 | $52 |
| Cyclobenzaprine | None | 35 | $529 | $15 |
| Venlafaxine Hcl Er | None | 38 | $447 | $12 |
| Amantadine | None | 13 | $446 | $34 |
| Tizanidine | None | 30 | $409 | $14 |
| Divalproex Sodium Er | None | 11 | $363 | $33 |
| Mirtazapine | None | 13 | $321 | $25 |
| Escitalopram | None | 25 | $289 | $12 |
| Bupropion Xl | None | 12 | $230 | $19 |
| Baclofen | None | 23 | $214 | $9 |
| Citalopram Hbr | None | 33 | $205 | $6 |
| Sertraline | None | 31 | $186 | $6 |
| Quetiapine | None | 22 | $165 | $7 |
| Tramadol | None | 25 | $139 | $6 |
| Lorazepam | None | 23 | $120 | $5 |
| Diazepam | None | 38 | $117 | $3 |
| Prednisone | None | 11 | $68 | $6 |
Year by year
| 2024 | 2,162 | 385 | 1% (25) | None | $591,954 |
| 2023 | 1,794 | 269 | 2% (27) | 17% | $426,174 |
| 2022 | 1,892 | 273 | 1% (23) | None | $390,713 |
| 2021 | 2,281 | 364 | 2% (38) | None | $582,762 |
| 2020 | 3,676 | 466 | 1% (28) | None | $1,515,299 |
| 2019 | 3,822 | 486 | 1% (43) | 23% | $1,764,587 |
| 2018 | 4,398 | 503 | 1% (36) | 29% | $2,007,871 |
| 2017 | 5,531 | 518 | 1% (57) | 33% | $2,159,103 |
| 2016 | 5,791 | 512 | 1% (77) | 36% | $2,480,926 |
| 2015 | 5,235 | 507 | 1% (60) | 42% | $2,349,557 |
| 2014 | 4,657 | 469 | 2% (84) | None | $1,636,998 |
| 2013 | 3,763 | 380 | 2% (65) | None | $985,112 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 42 drugs
| Nuedexta | None | 76 | $121,229 | $1,595 |
| Aimovig | Migraine | 62 | $64,126 | $1,034 |
| Emgality | Migraine | 37 | $30,311 | $819 |
| Nurtec Odt | None | 16 | $23,768 | $1,486 |
| Ubrelvy | None | 19 | $23,245 | $1,223 |
| Ajovy | None | 20 | $19,652 | $983 |
| Ajovy | None | 21 | $14,709 | $700 |
| Rivastigmine | None | 40 | $11,598 | $290 |
| Neupro | None | 11 | $9,485 | $862 |
| Rivastigmine | None | 89 | $8,975 | $101 |
| Memantine | None | 112 | $7,044 | $63 |
| Namzaric | None | 11 | $6,706 | $610 |
| Donepezil | None | 198 | $3,992 | $20 |
| Gabapentin | None | 129 | $2,859 | $22 |
| Pregabalin | None | 67 | $2,385 | $36 |
| Quetiapine | None | 16 | $2,000 | $125 |
| Dextroamphetamine-Amphetamine | None | 29 | $1,554 | $54 |
| Nortriptyline | None | 50 | $1,390 | $28 |
| Topiramate | None | 52 | $1,345 | $26 |
| Duloxetine | None | 31 | $1,095 | $35 |
| Carbidopa-Levodopa | None | 20 | $877 | $44 |
| Rizatriptan | None | 43 | $871 | $20 |
| Amitriptyline | None | 22 | $781 | $35 |
| Sumatriptan | None | 32 | $694 | $22 |
| Divalproex Sodium Er | None | 13 | $580 | $45 |
| Citalopram Hbr | None | 62 | $531 | $9 |
| Venlafaxine Hcl Er | None | 21 | $480 | $23 |
| Baclofen | None | 19 | $444 | $23 |
| Tizanidine | None | 32 | $410 | $13 |
| Bupropion Xl | None | 19 | $386 | $20 |
| Divalproex | None | 14 | $351 | $25 |
| Sertraline | None | 27 | $331 | $12 |
| Clopidogrel | None | 14 | $259 | $19 |
| Risperidone | None | 24 | $233 | $10 |
| Mirtazapine | None | 17 | $220 | $13 |
| Cyclobenzaprine | None | 31 | $165 | $5 |
| Lorazepam | None | 23 | $163 | $7 |
| Clonazepam | None | 11 | $123 | $11 |
| Trazodone | None | 11 | $89 | $8 |
| Tramadol | None | 25 | $80 | $3 |
| Methylprednisolone | None | 11 | $55 | $5 |
| Diazepam | None | 32 | $34 | $1 |
2022: 38 drugs
| Nuedexta | None | 96 | $147,962 | $1,541 |
| Aimovig | Migraine | 59 | $63,188 | $1,071 |
| Ubrelvy | None | 26 | $27,034 | $1,040 |
| Ajovy | None | 22 | $19,899 | $904 |
| Ajovy | None | 21 | $16,371 | $780 |
| Rivastigmine | None | 49 | $14,147 | $289 |
| Rivastigmine | None | 129 | $8,950 | $69 |
| Sirolimus | None | 15 | $8,854 | $590 |
| Memantine | None | 133 | $8,533 | $64 |
| Donepezil | None | 219 | $3,754 | $17 |
| Gabapentin | None | 167 | $3,240 | $19 |
| Quetiapine | None | 28 | $2,900 | $104 |
| Carbidopa-Levodopa | None | 33 | $2,191 | $66 |
| Dextroamphetamine-Amphetamine | None | 38 | $2,129 | $56 |
| Topiramate | None | 58 | $1,484 | $26 |
| Pregabalin | None | 42 | $1,188 | $28 |
| Sumatriptan | None | 17 | $1,051 | $62 |
| Amitriptyline | None | 27 | $1,017 | $38 |
| Nortriptyline | None | 43 | $978 | $23 |
| Duloxetine | None | 40 | $898 | $22 |
| Tizanidine | None | 28 | $860 | $31 |
| Mirtazapine | None | 34 | $748 | $22 |
| Bupropion Xl | None | 28 | $717 | $26 |
| Lorazepam | None | 27 | $672 | $25 |
| Rizatriptan | None | 21 | $653 | $31 |
| Divalproex | None | 15 | $548 | $37 |
| Baclofen | None | 24 | $497 | $21 |
| Amantadine | None | 11 | $486 | $44 |
| Divalproex Sodium Er | None | 17 | $449 | $26 |
| Venlafaxine Hcl Er | None | 18 | $446 | $25 |
| Sertraline | None | 28 | $415 | $15 |
| Minocycline | None | 16 | $389 | $24 |
| Citalopram Hbr | None | 62 | $369 | $6 |
| Risperidone | None | 28 | $340 | $12 |
| Clopidogrel | None | 16 | $338 | $21 |
| Tramadol | None | 23 | $213 | $9 |
| Cyclobenzaprine | None | 28 | $163 | $6 |
| Diazepam | None | 16 | $12 | $1 |
2021: 40 drugs
| Nuedexta | None | 154 | $236,122 | $1,533 |
| Aimovig | Migraine | 88 | $63,014 | $716 |
| Rivastigmine | None | 106 | $28,608 | $270 |
| Ajovy | None | 28 | $18,731 | $669 |
| Ajovy | None | 25 | $16,138 | $646 |
| Rasagiline Mesylate | None | 26 | $14,185 | $546 |
| Ubrelvy | None | 14 | $13,149 | $939 |
| Memantine | None | 191 | $12,804 | $67 |
| Rivastigmine | None | 104 | $10,887 | $105 |
| Namzaric | None | 12 | $6,528 | $544 |
| Carbidopa-Levodopa | None | 71 | $4,776 | $67 |
| Gabapentin | None | 171 | $4,636 | $27 |
| Donepezil | None | 288 | $4,331 | $15 |
| Carbamazepine Er | None | 11 | $2,931 | $266 |
| Dextroamphetamine-Amphetamine | None | 40 | $2,355 | $59 |
| Duloxetine | None | 73 | $1,814 | $25 |
| Nortriptyline | None | 71 | $1,758 | $25 |
| Topiramate | None | 55 | $1,534 | $28 |
| Pregabalin | None | 36 | $1,462 | $41 |
| Amitriptyline | None | 32 | $1,180 | $37 |
| Rizatriptan | None | 20 | $1,022 | $51 |
| Tizanidine | None | 30 | $922 | $31 |
| Bupropion Xl | None | 27 | $817 | $30 |
| Mirtazapine | None | 22 | $673 | $31 |
| Carbidopa-Levodopa Er | None | 11 | $571 | $52 |
| Clonazepam | None | 23 | $567 | $25 |
| Levetiracetam | None | 14 | $509 | $36 |
| Sertraline | None | 39 | $461 | $12 |
| Venlafaxine Hcl Er | None | 17 | $365 | $21 |
| Ropinirole | None | 13 | $363 | $28 |
| Quetiapine | None | 21 | $351 | $17 |
| Tramadol | None | 29 | $328 | $11 |
| Citalopram Hbr | None | 47 | $306 | $7 |
| Baclofen | None | 23 | $300 | $13 |
| Divalproex | None | 12 | $287 | $24 |
| Clopidogrel | None | 18 | $172 | $10 |
| Cyclobenzaprine | None | 18 | $165 | $9 |
| Trazodone | None | 11 | $114 | $10 |
| Lorazepam | None | 11 | $110 | $10 |
| Diazepam | None | 17 | $18 | $1 |
2020: 58 drugs
| Nuedexta | None | 205 | $288,705 | $1,408 |
| Nuplazid | Parkinson's psychosis | 47 | $180,772 | $3,846 |
| Vimpat | None | 61 | $85,557 | $1,403 |
| Copaxone | None | 14 | $82,308 | $5,879 |
| Tetrabenazine | None | 12 | $76,179 | $6,348 |
| Glatiramer Acetate | None | 15 | $75,496 | $5,033 |
| Aimovig | Migraine | 103 | $68,904 | $669 |
| Neupro | None | 53 | $46,994 | $887 |
| Rivastigmine | None | 167 | $44,617 | $267 |
| Ampyra | None | 13 | $38,417 | $2,955 |
| Rytary | Parkinson's | 39 | $38,277 | $981 |
| Rasagiline Mesylate | None | 75 | $36,298 | $484 |
| Rivastigmine | None | 182 | $25,243 | $139 |
| Gralise | None | 18 | $20,274 | $1,126 |
| Ajovy | None | 32 | $19,701 | $616 |
| Exelon | None | 20 | $14,190 | $710 |
| Emgality | Migraine | 16 | $13,383 | $836 |
| Carbidopa-Levodopa | None | 301 | $11,803 | $39 |
| Memantine | None | 133 | $8,988 | $68 |
| Carbamazepine Er | None | 27 | $7,684 | $285 |
| Donepezil | None | 352 | $5,531 | $16 |
| Gabapentin | None | 171 | $4,544 | $27 |
| Memantine Hcl Er | None | 19 | $4,116 | $217 |
| Lamotrigine Er | None | 15 | $4,050 | $270 |
| Carbidopa-Levodopa Er | None | 31 | $2,931 | $95 |
| Duloxetine | None | 91 | $2,876 | $32 |
| Topiramate | None | 84 | $2,344 | $28 |
| Levetiracetam | None | 79 | $2,289 | $29 |
| Pregabalin | None | 32 | $2,229 | $70 |
| Oxcarbazepine | None | 16 | $2,076 | $130 |
| Amantadine | None | 16 | $1,874 | $117 |
| Nortriptyline | None | 129 | $1,835 | $14 |
| Clonazepam | None | 128 | $1,437 | $11 |
| Amitriptyline | None | 34 | $1,309 | $39 |
| Rizatriptan | None | 36 | $1,309 | $36 |
| Quetiapine | None | 56 | $1,168 | $21 |
| Dextroamphetamine-Amphetamine | None | 31 | $1,102 | $36 |
| Baclofen | None | 23 | $1,100 | $48 |
| Lamotrigine | None | 41 | $1,069 | $26 |
| Pramipexole Dihydrochloride | None | 29 | $954 | $33 |
| Sertraline | None | 90 | $902 | $10 |
| Mirtazapine | None | 17 | $890 | $52 |
| Primidone | None | 33 | $854 | $26 |
| Bupropion Xl | None | 29 | $627 | $22 |
| Divalproex | None | 34 | $614 | $18 |
| Ropinirole | None | 21 | $555 | $26 |
| Citalopram Hbr | None | 61 | $510 | $8 |
| Venlafaxine Hcl Er | None | 27 | $425 | $16 |
| Quetiapine Fumarate Er | None | 12 | $385 | $32 |
| Zonisamide | None | 18 | $318 | $18 |
| Tizanidine | None | 28 | $279 | $10 |
| Tramadol | None | 24 | $253 | $11 |
| Omeprazole | None | 12 | $160 | $13 |
| Trazodone | None | 13 | $142 | $11 |
| Cyclobenzaprine | None | 17 | $134 | $8 |
| Lorazepam | None | 16 | $126 | $8 |
| Clopidogrel | None | 15 | $125 | $8 |
| Diazepam | None | 26 | $33 | $1 |
2019: 72 drugs
| Nuedexta | None | 232 | $329,689 | $1,421 |
| Tetrabenazine | None | 24 | $189,834 | $7,910 |
| Aubagio | None | 16 | $161,285 | $10,080 |
| Nuplazid | Parkinson's psychosis | 39 | $133,891 | $3,433 |
| Copaxone | None | 15 | $88,533 | $5,902 |
| Vimpat | None | 63 | $85,593 | $1,359 |
| Glatiramer Acetate | None | 16 | $79,282 | $4,955 |
| Neupro | None | 61 | $48,178 | $790 |
| Rivastigmine | None | 164 | $45,256 | $276 |
| Rytary | Parkinson's | 43 | $43,979 | $1,023 |
| Rasagiline Mesylate | None | 78 | $42,696 | $547 |
| Ajovy | None | 66 | $39,107 | $593 |
| Ampyra | None | 13 | $35,977 | $2,767 |
| Aimovig | Migraine | 51 | $31,735 | $622 |
| Namzaric | None | 32 | $21,109 | $660 |
| Xadago | None | 18 | $20,234 | $1,124 |
| Emgality | Migraine | 24 | $19,347 | $806 |
| Memantine Hcl Er | None | 46 | $14,244 | $310 |
| Exelon | None | 20 | $13,971 | $699 |
| Dalfampridine Er | None | 12 | $13,539 | $1,128 |
| Rivastigmine | None | 99 | $11,418 | $115 |
| Carbidopa-Levodopa | None | 322 | $11,320 | $35 |
| Fluphenazine | None | 12 | $8,816 | $735 |
| Lyrica | None | 12 | $7,621 | $635 |
| Lamotrigine Er | None | 20 | $6,383 | $319 |
| Duloxetine | None | 72 | $6,069 | $84 |
| Memantine | None | 95 | $5,814 | $61 |
| Carbamazepine Er | None | 25 | $5,622 | $225 |
| Donepezil | None | 432 | $5,516 | $13 |
| Eletriptan Hbr | None | 12 | $5,160 | $430 |
| Gabapentin | None | 202 | $4,643 | $23 |
| Modafinil | None | 14 | $3,358 | $240 |
| Carbidopa-Levodopa Er | None | 41 | $2,694 | $66 |
| Ropinirole Er | None | 11 | $2,616 | $238 |
| Levetiracetam Er | None | 12 | $2,591 | $216 |
| Amantadine | None | 20 | $2,302 | $115 |
| Levetiracetam | None | 67 | $1,951 | $29 |
| Baclofen | None | 53 | $1,868 | $35 |
| Oxcarbazepine | None | 18 | $1,863 | $103 |
| Rizatriptan | None | 34 | $1,632 | $48 |
| Amitriptyline | None | 57 | $1,586 | $28 |
| Divalproex Sodium Er | None | 28 | $1,585 | $57 |
| Topiramate | None | 78 | $1,554 | $20 |
| Primidone | None | 19 | $1,492 | $79 |
| Phenytoin Sodium Extended | None | 19 | $1,361 | $72 |
| Quetiapine | None | 76 | $1,206 | $16 |
| Ropinirole | None | 19 | $1,037 | $55 |
| Nortriptyline | None | 63 | $1,029 | $16 |
| Dextroamphetamine-Amphetamine | None | 27 | $917 | $34 |
| Divalproex | None | 34 | $862 | $25 |
| Butalbital-Aspirin-Caffeine | None | 13 | $820 | $63 |
| Pramipexole Dihydrochloride | None | 20 | $815 | $41 |
| Clonazepam | None | 96 | $813 | $8 |
| Lamotrigine | None | 46 | $784 | $17 |
| Sumatriptan | None | 11 | $684 | $62 |
| Oxybutynin Chloride | None | 18 | $640 | $36 |
| Bupropion Xl | None | 24 | $595 | $25 |
| Sertraline | None | 40 | $552 | $14 |
| Citalopram Hbr | None | 60 | $468 | $8 |
| Phenobarbital | None | 13 | $456 | $35 |
| Venlafaxine Hcl Er | None | 20 | $427 | $21 |
| Tramadol | None | 35 | $358 | $10 |
| Escitalopram | None | 24 | $319 | $13 |
| Tizanidine | None | 16 | $279 | $17 |
| Lorazepam | None | 17 | $233 | $14 |
| Clopidogrel | None | 25 | $231 | $9 |
| Cyclobenzaprine | None | 18 | $186 | $10 |
| Mirtazapine | None | 11 | $161 | $15 |
| Omeprazole | None | 16 | $157 | $10 |
| Trazodone | None | 15 | $74 | $5 |
| Diazepam | None | 42 | $56 | $1 |
| Prednisone | None | 13 | $47 | $4 |
2018: 67 drugs
| Nuedexta | None | 348 | $393,367 | $1,130 |
| Copaxone | None | 23 | $228,237 | $9,923 |
| Vimpat | None | 163 | $197,284 | $1,210 |
| Nuplazid | Parkinson's psychosis | 36 | $124,994 | $3,472 |
| Aubagio | None | 14 | $122,791 | $8,771 |
| Rasagiline Mesylate | None | 115 | $69,931 | $608 |
| Neupro | None | 69 | $49,773 | $721 |
| Glatiramer Acetate | None | 13 | $48,760 | $3,751 |
| Ampyra | None | 15 | $44,302 | $2,953 |
| Rivastigmine | None | 110 | $39,744 | $361 |
| Exelon | None | 51 | $34,849 | $683 |
| Namzaric | None | 68 | $33,682 | $495 |
| Lyrica | None | 32 | $31,214 | $975 |
| Namenda Xr | None | 52 | $24,857 | $478 |
| Rytary | Parkinson's | 25 | $21,368 | $855 |
| Memantine Hcl Er | None | 55 | $20,929 | $381 |
| Fycompa | None | 17 | $17,241 | $1,014 |
| Gralise | None | 15 | $15,375 | $1,025 |
| Carbidopa-Levodopa | None | 322 | $12,890 | $40 |
| Duloxetine | None | 108 | $9,808 | $91 |
| Horizant | None | 15 | $9,664 | $644 |
| Onfi | None | 12 | $9,389 | $782 |
| Banzel | None | 14 | $9,278 | $663 |
| Carbamazepine Er | None | 49 | $7,914 | $162 |
| Divalproex Sodium Er | None | 53 | $6,732 | $127 |
| Donepezil | None | 499 | $6,128 | $12 |
| Gabapentin | None | 219 | $4,531 | $21 |
| Rivastigmine | None | 31 | $4,427 | $143 |
| Tegretol Xr | None | 13 | $3,732 | $287 |
| Levetiracetam | None | 89 | $3,685 | $41 |
| Ropinirole Er | None | 18 | $3,239 | $180 |
| Amantadine | None | 31 | $3,203 | $103 |
| Memantine | None | 53 | $3,110 | $59 |
| Carbidopa-Levodopa Er | None | 52 | $2,837 | $55 |
| Topiramate | None | 142 | $2,483 | $17 |
| Baclofen | None | 72 | $1,931 | $27 |
| Amitriptyline | None | 90 | $1,920 | $21 |
| Quetiapine | None | 113 | $1,726 | $15 |
| Ropinirole | None | 32 | $1,593 | $50 |
| Lamotrigine | None | 85 | $1,421 | $17 |
| Nortriptyline | None | 65 | $1,260 | $19 |
| Levetiracetam Er | None | 22 | $1,202 | $55 |
| Rizatriptan | None | 18 | $1,179 | $65 |
| Phenytoin Sodium Extended | None | 32 | $1,161 | $36 |
| Butalbital-Aspirin-Caffeine | None | 16 | $1,153 | $72 |
| Primidone | None | 27 | $1,097 | $41 |
| Sumatriptan | None | 12 | $1,074 | $89 |
| Phenobarbital | None | 37 | $874 | $24 |
| Dextroamphetamine-Amphet Er | None | 12 | $845 | $70 |
| Bupropion Xl | None | 23 | $834 | $36 |
| Clonazepam | None | 104 | $822 | $8 |
| Oxcarbazepine | None | 14 | $649 | $46 |
| Tramadol | None | 30 | $574 | $19 |
| Citalopram Hbr | None | 71 | $569 | $8 |
| Divalproex | None | 22 | $489 | $22 |
| Pramipexole Dihydrochloride | None | 25 | $457 | $18 |
| Sertraline | None | 25 | $434 | $17 |
| Venlafaxine Hcl Er | None | 17 | $384 | $23 |
| Zonisamide | None | 20 | $360 | $18 |
| Tizanidine | None | 20 | $315 | $16 |
| Clopidogrel | None | 40 | $222 | $6 |
| Omeprazole | None | 17 | $183 | $11 |
| Trazodone | None | 22 | $145 | $7 |
| Escitalopram | None | 13 | $123 | $9 |
| Naproxen | None | 11 | $96 | $9 |
| Diazepam | None | 32 | $67 | $2 |
| Simvastatin | None | 11 | $21 | $2 |
2017: 70 drugs
| Copaxone | None | 57 | $427,142 | $7,494 |
| Nuedexta | None | 495 | $396,648 | $801 |
| Vimpat | None | 280 | $259,998 | $929 |
| Aubagio | None | 14 | $125,026 | $8,930 |
| Neupro | None | 130 | $85,656 | $659 |
| Namenda Xr | None | 183 | $81,832 | $447 |
| Rasagiline Mesylate | None | 150 | $81,243 | $542 |
| Nuplazid | Parkinson's psychosis | 33 | $70,470 | $2,135 |
| Rivastigmine | None | 146 | $49,143 | $337 |
| Lyrica | None | 39 | $48,908 | $1,254 |
| Exelon | None | 56 | $37,723 | $674 |
| Namzaric | None | 84 | $34,057 | $405 |
| Fycompa | None | 38 | $29,641 | $780 |
| Azilect | None | 30 | $26,902 | $897 |
| Onfi | None | 25 | $20,130 | $805 |
| Lamotrigine Odt | None | 38 | $14,710 | $387 |
| Trokendi Xr | None | 19 | $12,451 | $655 |
| Gralise | None | 16 | $12,254 | $766 |
| Divalproex Sodium Er | None | 84 | $11,054 | $132 |
| Carbamazepine Er | None | 70 | $10,027 | $143 |
| Duloxetine | None | 122 | $9,473 | $78 |
| Rivastigmine | None | 71 | $8,399 | $118 |
| Carbidopa-Levodopa | None | 302 | $8,039 | $27 |
| Rytary | Parkinson's | 17 | $7,513 | $442 |
| Donepezil | None | 637 | $6,273 | $10 |
| Banzel | None | 14 | $6,010 | $429 |
| Ropinirole Er | None | 25 | $4,566 | $183 |
| Gabapentin | None | 202 | $4,421 | $22 |
| Lidocaine-Prilocaine | None | 17 | $3,902 | $230 |
| Memantine | None | 54 | $3,873 | $72 |
| Levetiracetam | None | 115 | $3,766 | $33 |
| Amantadine | None | 33 | $3,410 | $103 |
| Topiramate | None | 176 | $2,786 | $16 |
| Amitriptyline | None | 164 | $2,589 | $16 |
| Quetiapine | None | 170 | $2,129 | $13 |
| Carbidopa-Levodopa Er | None | 39 | $2,085 | $53 |
| Phenytoin Sodium Extended | None | 52 | $2,079 | $40 |
| Ropinirole | None | 41 | $1,953 | $48 |
| Primidone | None | 53 | $1,813 | $34 |
| Methylphenidate Er | None | 11 | $1,702 | $155 |
| Carbamazepine | None | 16 | $1,553 | $97 |
| Baclofen | None | 58 | $1,385 | $24 |
| Divalproex | None | 44 | $1,375 | $31 |
| Lamotrigine | None | 71 | $1,116 | $16 |
| Dextroamphetamine-Amphet Er | None | 11 | $959 | $87 |
| Sumatriptan | None | 18 | $926 | $51 |
| Oxcarbazepine | None | 20 | $835 | $42 |
| Sertraline | None | 55 | $833 | $15 |
| Nortriptyline | None | 59 | $735 | $12 |
| Celecoxib | None | 12 | $703 | $59 |
| Tramadol | None | 44 | $637 | $14 |
| Clonazepam | None | 112 | $633 | $6 |
| Phenobarbital | None | 30 | $584 | $19 |
| Rizatriptan | None | 18 | $575 | $32 |
| Zonisamide | None | 26 | $548 | $21 |
| Clopidogrel | None | 66 | $529 | $8 |
| Citalopram Hbr | None | 74 | $504 | $7 |
| Pramipexole Dihydrochloride | None | 21 | $389 | $19 |
| Venlafaxine Hcl Er | None | 41 | $352 | $9 |
| Mirtazapine | None | 18 | $337 | $19 |
| Tizanidine | None | 27 | $297 | $11 |
| Bupropion Xl | None | 13 | $278 | $21 |
| Propranolol | None | 13 | $243 | $19 |
| Trazodone | None | 29 | $218 | $8 |
| Omeprazole | None | 23 | $191 | $8 |
| Naproxen | None | 16 | $135 | $8 |
| Lorazepam | None | 24 | $105 | $4 |
| Alprazolam | None | 14 | $55 | $4 |
| Diazepam | None | 16 | $27 | $2 |
| Simvastatin | None | 12 | $20 | $2 |
2016: 79 drugs
| H.P. Acthar | None | 12 | $447,750 | $37,312 |
| Copaxone | None | 75 | $447,646 | $5,969 |
| Nuedexta | None | 595 | $430,596 | $724 |
| Vimpat | None | 356 | $267,921 | $753 |
| Azilect | None | 195 | $143,419 | $735 |
| Aubagio | None | 14 | $113,132 | $8,081 |
| Namenda Xr | None | 180 | $76,879 | $427 |
| Neupro | None | 104 | $70,090 | $674 |
| Exelon | None | 98 | $58,032 | $592 |
| Rivastigmine | None | 122 | $48,876 | $401 |
| Lyrica | None | 50 | $43,334 | $867 |
| Onfi | None | 35 | $24,838 | $710 |
| Ampyra | None | 11 | $21,178 | $1,925 |
| Lidocaine-Prilocaine | None | 32 | $16,426 | $513 |
| Lamotrigine Odt | None | 36 | $15,719 | $437 |
| Fycompa | None | 20 | $14,703 | $735 |
| Lamictal Xr | None | 23 | $14,151 | $615 |
| Divalproex Sodium Er | None | 94 | $11,907 | $127 |
| Donepezil | None | 615 | $10,463 | $17 |
| Trokendi Xr | None | 19 | $9,571 | $504 |
| Gralise | None | 16 | $8,761 | $548 |
| Namzaric | None | 21 | $7,717 | $367 |
| Ropinirole Er | None | 41 | $7,363 | $180 |
| Carbidopa-Levodopa | None | 297 | $6,604 | $22 |
| Lamotrigine Er | None | 14 | $6,547 | $468 |
| Relpax | None | 17 | $6,258 | $368 |
| Seroquel Xr | None | 11 | $5,627 | $512 |
| Rivastigmine | None | 59 | $5,521 | $94 |
| Duloxetine | None | 59 | $5,494 | $93 |
| Memantine | None | 68 | $5,368 | $79 |
| Rytary | Parkinson's | 17 | $5,231 | $308 |
| Gabapentin | None | 198 | $4,662 | $24 |
| Amantadine | None | 37 | $4,549 | $123 |
| Levetiracetam | None | 147 | $3,862 | $26 |
| Topiramate | None | 183 | $3,674 | $20 |
| Banzel | None | 18 | $3,401 | $189 |
| Carbamazepine Er | None | 38 | $3,151 | $83 |
| Amitriptyline | None | 196 | $2,896 | $15 |
| Quetiapine | None | 158 | $2,816 | $18 |
| Dextroamphetamine-Amphet Er | None | 13 | $2,464 | $190 |
| Phenytoin Sodium Extended | None | 42 | $2,216 | $53 |
| Baclofen | None | 57 | $2,070 | $36 |
| Ropinirole | None | 34 | $2,054 | $60 |
| Carbidopa-Levodopa Er | None | 56 | $1,992 | $36 |
| Carbamazepine | None | 20 | $1,813 | $91 |
| Primidone | None | 51 | $1,675 | $33 |
| Butalbital-Aspirin-Caffeine | None | 24 | $1,651 | $69 |
| Clonazepam | None | 128 | $1,471 | $11 |
| Methylphenidate Er | None | 11 | $1,462 | $133 |
| Divalproex | None | 45 | $1,293 | $29 |
| Tramadol Hcl Er | None | 16 | $1,106 | $69 |
| Lamotrigine | None | 53 | $966 | $18 |
| Bupropion | None | 19 | $791 | $42 |
| Celecoxib | None | 13 | $782 | $60 |
| Tizanidine | None | 44 | $726 | $17 |
| Pramipexole Dihydrochloride | None | 32 | $704 | $22 |
| Rizatriptan | None | 11 | $651 | $59 |
| Epitol | None | 11 | $620 | $56 |
| Clopidogrel | None | 49 | $566 | $12 |
| Sertraline | None | 60 | $565 | $9 |
| Nortriptyline | None | 33 | $525 | $16 |
| Tramadol | None | 35 | $502 | $14 |
| Venlafaxine Hcl Er | None | 49 | $496 | $10 |
| Sumatriptan | None | 27 | $455 | $17 |
| Oxcarbazepine | None | 14 | $434 | $31 |
| Trazodone | None | 48 | $367 | $8 |
| Lorazepam | None | 68 | $367 | $5 |
| Naratriptan | None | 14 | $364 | $26 |
| Zonisamide | None | 22 | $354 | $16 |
| Diazepam | None | 35 | $351 | $10 |
| Citalopram Hbr | None | 40 | $349 | $9 |
| Phenobarbital | None | 24 | $313 | $13 |
| Butalbital-Acetaminophen-Caffe | None | 14 | $260 | $19 |
| Olanzapine | None | 13 | $185 | $14 |
| Omeprazole | None | 30 | $177 | $6 |
| Hydrocodone-Acetaminophen | None | 16 | $138 | $9 |
| Paroxetine | None | 15 | $95 | $6 |
| Prednisone | None | 15 | $69 | $5 |
| Simvastatin | None | 13 | $21 | $2 |
2015: 69 drugs
| H.P. Acthar | 16 | $537,109 | $33,569 |
| Nuedexta | 618 | $413,105 | $668 |
| Copaxone | 65 | $375,676 | $5,780 |
| Vimpat | 383 | $267,437 | $698 |
| Exelon | 211 | $115,553 | $548 |
| Azilect | 153 | $106,040 | $693 |
| Namenda Xr | 191 | $66,750 | $349 |
| Neupro | 110 | $64,501 | $586 |
| Lyrica | 40 | $26,226 | $656 |
| Onfi | 27 | $25,185 | $933 |
| Namenda | 64 | $24,496 | $383 |
| Divalproex Sodium Er | 81 | $11,686 | $144 |
| Lamotrigine Odt | 26 | $11,296 | $434 |
| Lamictal Xr | 24 | $10,671 | $445 |
| Rivastigmine | 28 | $10,006 | $357 |
| Duloxetine | 73 | $9,481 | $130 |
| Aggrenox | 16 | $8,919 | $557 |
| Nuvigil | 12 | $8,438 | $703 |
| Donepezil | 507 | $7,998 | $16 |
| Gralise | 19 | $7,488 | $394 |
| Rivastigmine | 42 | $6,418 | $153 |
| Sinemet 25-100 | 17 | $6,254 | $368 |
| Ropinirole Er | 47 | $5,910 | $126 |
| Carbamazepine Er | 54 | $5,850 | $108 |
| Carbidopa-Levodopa | 218 | $4,854 | $22 |
| Seroquel Xr | 11 | $4,776 | $434 |
| Gabapentin | 143 | $3,592 | $25 |
| Levetiracetam | 137 | $3,434 | $25 |
| Amantadine | 32 | $3,398 | $106 |
| Amitriptyline | 203 | $3,139 | $15 |
| Memantine | 20 | $3,117 | $156 |
| Carbidopa-Levodopa Er | 47 | $2,929 | $62 |
| Ropinirole | 35 | $2,731 | $78 |
| Phenytoin Sodium Extended | 44 | $2,653 | $60 |
| Methylphenidate Er | 13 | $2,404 | $185 |
| Carbamazepine | 23 | $2,153 | $94 |
| Baclofen | 46 | $2,078 | $45 |
| Topiramate | 144 | $1,917 | $13 |
| Divalproex | 45 | $1,278 | $28 |
| Quetiapine | 117 | $1,269 | $11 |
| Primidone | 45 | $1,177 | $26 |
| Tizanidine | 51 | $1,125 | $22 |
| Celecoxib | 11 | $1,056 | $96 |
| Butalbital-Aspirin-Caffeine | 15 | $1,024 | $68 |
| Bupropion | 17 | $839 | $49 |
| Butalbital-Acetaminophen-Caffe | 15 | $695 | $46 |
| Zonisamide | 39 | $641 | $16 |
| Lamotrigine | 35 | $595 | $17 |
| Epitol | 12 | $582 | $49 |
| Sertraline | 72 | $555 | $8 |
| Naratriptan | 13 | $539 | $41 |
| Clonazepam | 111 | $520 | $5 |
| Citalopram Hbr | 94 | $514 | $5 |
| Pramipexole Dihydrochloride | 21 | $507 | $24 |
| Clopidogrel | 27 | $375 | $14 |
| Lorazepam | 56 | $363 | $6 |
| Sumatriptan | 20 | $357 | $18 |
| Tramadol | 25 | $345 | $14 |
| Nortriptyline | 30 | $303 | $10 |
| Venlafaxine Hcl Er | 32 | $270 | $8 |
| Hydrocodone-Acetaminophen | 22 | $261 | $12 |
| Phenobarbital | 22 | $198 | $9 |
| Olanzapine | 12 | $191 | $16 |
| Benztropine Mesylate | 11 | $163 | $15 |
| Trazodone | 29 | $163 | $6 |
| Paroxetine | 14 | $120 | $9 |
| Diazepam | 30 | $83 | $3 |
| Alprazolam | 11 | $72 | $7 |
| Cyclobenzaprine | 11 | $48 | $4 |
2014: 63 drugs
| H.P. Acthar | 11 | $354,479 | $32,225 |
| Nuedexta | 361 | $235,536 | $652 |
| Vimpat | 337 | $223,164 | $662 |
| Copaxone | 31 | $151,046 | $4,872 |
| Exelon | 320 | $136,154 | $425 |
| Namenda | 189 | $76,046 | $402 |
| Azilect | 104 | $74,578 | $717 |
| Neupro | 128 | $65,228 | $510 |
| Namenda Xr | 178 | $57,311 | $322 |
| Onfi | 24 | $20,290 | $845 |
| Lidocaine-Prilocaine | 66 | $17,701 | $268 |
| Lamictal Odt | 37 | $15,635 | $423 |
| Lyrica | 19 | $14,257 | $750 |
| Duloxetine | 55 | $14,014 | $255 |
| Aggrenox | 23 | $10,065 | $438 |
| Divalproex Sodium Er | 55 | $9,906 | $180 |
| Donepezil | 320 | $9,854 | $31 |
| Lamictal Xr | 22 | $8,923 | $406 |
| Nuvigil | 12 | $8,919 | $743 |
| Quetiapine | 174 | $8,549 | $49 |
| Ropinirole | 80 | $7,281 | $91 |
| Carbamazepine Xr | 47 | $5,958 | $127 |
| Gralise | 17 | $5,665 | $333 |
| Seroquel Xr | 13 | $5,325 | $410 |
| Sinemet 25-100 | 13 | $5,095 | $392 |
| Carbidopa-Levodopa | 162 | $5,058 | $31 |
| Levetiracetam | 148 | $4,686 | $32 |
| Orap | 11 | $4,320 | $393 |
| Gabapentin | 120 | $3,375 | $28 |
| Carbamazepine | 47 | $2,707 | $58 |
| Primidone | 70 | $2,602 | $37 |
| Divalproex | 46 | $2,426 | $53 |
| Entacapone | 11 | $2,306 | $210 |
| Methylphenidate Er | 11 | $1,810 | $165 |
| Topiramate | 92 | $1,612 | $18 |
| Phenytoin Sodium Extended | 46 | $1,467 | $32 |
| Amitriptyline | 192 | $1,370 | $7 |
| Tizanidine | 56 | $1,172 | $21 |
| Zonisamide | 38 | $783 | $21 |
| Citalopram Hbr | 102 | $694 | $7 |
| Sertraline | 91 | $638 | $7 |
| Bupropion | 11 | $609 | $55 |
| Lorazepam | 41 | $594 | $14 |
| Propranolol Hcl Er | 12 | $504 | $42 |
| Pramipexole Dihydrochloride | 25 | $498 | $20 |
| Escitalopram | 23 | $463 | $20 |
| Tramadol | 40 | $437 | $11 |
| Hydrocodone-Acetaminophen | 31 | $417 | $13 |
| Clonazepam | 76 | $400 | $5 |
| Baclofen | 25 | $384 | $15 |
| Indomethacin | 12 | $381 | $32 |
| Lamotrigine | 31 | $369 | $12 |
| Sumatriptan | 23 | $367 | $16 |
| Carbidopa-Levodopa Er | 14 | $339 | $24 |
| Benztropine Mesylate | 17 | $301 | $18 |
| Venlafaxine Hcl Er | 26 | $286 | $11 |
| Risperidone | 12 | $216 | $18 |
| Mirtazapine | 14 | $214 | $15 |
| Nortriptyline | 12 | $190 | $16 |
| Alprazolam | 20 | $159 | $8 |
| Paroxetine | 12 | $148 | $12 |
| Cyclobenzaprine | 13 | $119 | $9 |
| Diazepam | 24 | $69 | $3 |
2013: 59 drugs
| Copaxone | 40 | $191,244 | $4,781 |
| Vimpat | 252 | $131,807 | $523 |
| Namenda | 293 | $95,952 | $327 |
| Exelon | 258 | $90,190 | $350 |
| Azilect | 130 | $72,404 | $557 |
| Neupro | 74 | $28,485 | $385 |
| Cymbalta | 62 | $20,179 | $325 |
| Quetiapine | 288 | $13,636 | $47 |
| Aricept | 33 | $12,358 | $374 |
| Lyrica | 28 | $12,063 | $431 |
| Lamictal Odt | 26 | $11,433 | $440 |
| Namenda Xr | 34 | $9,645 | $284 |
| Entacapone | 12 | $8,433 | $703 |
| Carbidopa-Levodopa | 188 | $8,029 | $43 |
| Lamictal Xr | 15 | $7,503 | $500 |
| Lidocaine-Prilocaine | 51 | $7,390 | $145 |
| Carbamazepine Xr | 41 | $6,791 | $166 |
| Donepezil | 237 | $5,978 | $25 |
| Levetiracetam | 116 | $5,944 | $51 |
| Aggrenox | 15 | $5,373 | $358 |
| Divalproex Sodium Er | 61 | $5,054 | $83 |
| Ropinirole | 20 | $3,641 | $182 |
| Gabapentin | 92 | $3,203 | $35 |
| Rivastigmine | 13 | $3,103 | $239 |
| Carbamazepine | 39 | $2,858 | $73 |
| Advair Diskus | 11 | $1,914 | $174 |
| Tizanidine | 42 | $1,871 | $45 |
| Divalproex | 51 | $1,734 | $34 |
| Primidone | 58 | $1,475 | $25 |
| Phenytoin Sodium Extended | 66 | $1,208 | $18 |
| Citalopram Hbr | 131 | $1,192 | $9 |
| Topiramate | 62 | $1,125 | $18 |
| Galantamine Hbr | 12 | $1,016 | $85 |
| Pramipexole Dihydrochloride | 34 | $989 | $29 |
| Phenytoin | 14 | $798 | $57 |
| Sertraline | 70 | $691 | $10 |
| Amitriptyline | 138 | $540 | $4 |
| Lorazepam | 26 | $510 | $20 |
| Zonisamide | 28 | $487 | $17 |
| Tramadol | 45 | $439 | $10 |
| Valproic Acid | 12 | $396 | $33 |
| Clonazepam | 61 | $383 | $6 |
| Venlafaxine Hcl Er | 24 | $325 | $14 |
| Indomethacin | 12 | $324 | $27 |
| Lamotrigine | 27 | $322 | $12 |
| Escitalopram | 11 | $300 | $27 |
| Temazepam | 23 | $284 | $12 |
| Oxcarbazepine | 11 | $271 | $25 |
| Fluticasone Propionate | 12 | $265 | $22 |
| Alprazolam | 23 | $259 | $11 |
| Propranolol | 13 | $177 | $14 |
| Losartan | 14 | $176 | $13 |
| Mirtazapine | 12 | $147 | $12 |
| Baclofen | 18 | $141 | $8 |
| Hydrocodone-Acetaminophen | 14 | $86 | $6 |
| Zolpidem | 11 | $68 | $6 |
| Trazodone | 11 | $65 | $6 |
| Diazepam | 21 | $51 | $2 |
| Prednisone | 11 | $49 | $4 |
Money from drug and device companies
$10,369 in 2025
| 2025 | 36 | 176 | $5,775 | $10,369 |
| 2024 | 32 | 162 | $13,725 | $17,805 |
| 2023 | 29 | 216 | $10,800 | $15,189 |
| 2022 | 33 | 280 | $32,428 | $38,689 |
| 2021 | 33 | 249 | $47,143 | $53,424 |
| 2020 | 25 | 191 | $43,660 | $49,895 |
| 2019 | 38 | 314 | $48,801 | $67,691 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Ubrelvy | $6,219 | 24 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $446 | 14 payments
|
| SK Life Science | None | $397 | 21 payments
|
| Noctrix Health | Nidra | $349 | 1 payment
|
| Pfizer | Nurtec Odt | $252 | 11 payments
|
| Lundbeck | Vyepti | $245 | 16 payments
|
See all 176 published payments
| SK Life Science | Meals · 2025-12-23 | None | $32 |
| Abbvie | Meals · 2025-12-18 | Botox | $17 |
| Ipsen Biopharmaceuticals | Meals · 2025-12-16 | Dysport | $27 |
| Vanda Pharmaceuticals | Meals · 2025-12-12 | Ponvory | $32 |
| Jazz Pharmaceuticals | Meals · 2025-12-12 | Epidiolex | $19 |
| Argenx US | Meals · 2025-12-10 | Vyvgart Hytrulo | $33 |
| ACADIA Pharmaceuticals | Meals · 2025-12-10 | Nuplazid | $24 |
| Amgen | Meals · 2025-12-08 | None | $20 |
| Merz Pharmaceuticals | Meals · 2025-12-05 | Inbrija | $34 |
| Octapharma USA | Meals · 2025-12-04 | Panzyga | $27 |
| Lundbeck | Meals · 2025-12-03 | Vyepti | $23 |
| Pfizer | Meals · 2025-12-02 | Nurtec Odt | $21 |
| Amneal Pharmaceuticals | Meals · 2025-11-20 | Crexont | $22 |
| Pfizer | Meals · 2025-11-18 | Nurtec Odt | $24 |
| Eisai | Meals · 2025-11-17 | Leqembi | $19 |
| Abbvie | Meals · 2025-11-12 | Ubrelvy | $4 |
| Teva Pharmaceuticals USA | Meals · 2025-11-12 | Austedo Xr | $3 |
| Teva Pharmaceuticals USA | Meals · 2025-11-12 | Austedo Xr | $32 |
| Alexion Pharmaceuticals | Meals · 2025-11-11 | Ultomiris | $31 |
| SK Life Science | Meals · 2025-11-08 | None | $35 |
| Vanda Pharmaceuticals | Meals · 2025-11-07 | Ponvory | $37 |
| CSL Behring | Meals · 2025-11-04 | Hizentra | $23 |
| Argenx US | Meals · 2025-11-04 | Vyvgart Hytrulo | $30 |
| Teva Pharmaceuticals USA | Meals · 2025-10-31 | Austedo Xr | $32 |
| Lundbeck | Meals · 2025-10-31 | Vyepti | $0 |
| Lundbeck | Meals · 2025-10-31 | Vyepti | $29 |
| Ucb | Meals · 2025-10-28 | Nayzilam | $21 |
| Pfizer | Meals · 2025-10-28 | Nurtec Odt | $26 |
| TG Therapeutics | Meals · 2025-10-25 | Briumvi | $28 |
| Merz Pharmaceuticals | Meals · 2025-10-23 | Xeomin | $28 |
| Merz Pharmaceuticals | Meals · 2025-10-23 | Xeomin | $4 |
| Otsuka America Pharmaceutical | Meals · 2025-10-20 | Rexulti | $20 |
| Axsome Therapeutics | Meals · 2025-10-17 | Symbravo | $28 |
| Eisai | Meals · 2025-10-16 | Leqembi | $32 |
| Abbvie | Meals · 2025-10-15 | Botox | $25 |
| TG Therapeutics | Meals · 2025-10-08 | Briumvi | $34 |
| Grifols USA | Meals · 2025-10-03 | Gamunex-C | $31 |
| SK Life Science | Meals · 2025-10-03 | None | $34 |
| Teva Pharmaceuticals USA | Meals · 2025-09-30 | Austedo Xr | $25 |
| Pfizer | Meals · 2025-09-24 | Nurtec Odt | $29 |
| Alexion Pharmaceuticals | Meals · 2025-09-23 | Ultomiris | $32 |
| Lundbeck | Meals · 2025-09-23 | Vyepti | $24 |
| Janssen Biotech | Meals · 2025-09-18 | None | $33 |
| Abbvie | Meals · 2025-09-17 | Ubrelvy | $25 |
| ACADIA Pharmaceuticals | Meals · 2025-09-16 | Nuplazid | $21 |
| Teva Pharmaceuticals USA | Meals · 2025-09-09 | Austedo Xr | $36 |
| Argenx US | Meals · 2025-09-08 | Vyvgart Hytrulo | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-05 | Wainua | $16 |
| SK Life Science | Meals · 2025-09-04 | None | $1 |
| SK Life Science | Meals · 2025-09-04 | None | $8 |
| Abbvie | Meals · 2025-09-03 | Botox | $14 |
| Neurocrine BioSciences | Meals · 2025-09-03 | Ingrezza | $31 |
| Abbvie | Meals · 2025-08-29 | Ubrelvy | $28 |
| Merz Pharmaceuticals | Meals · 2025-08-27 | Xeomin | $19 |
| Lundbeck | Meals · 2025-08-21 | Vyepti | $20 |
| Lundbeck | Meals · 2025-08-21 | Vyepti | $0 |
| Jazz Pharmaceuticals | Meals · 2025-08-20 | Epidiolex | $27 |
| Alexion Pharmaceuticals | Meals · 2025-08-19 | Ultomiris | $33 |
| Pfizer | Meals · 2025-08-19 | Nurtec Odt | $17 |
| Boston Scientific | Meals · 2025-08-15 | Wavewriter Alpha Prime 16 | $52 |
| Argenx US | Meals · 2025-08-14 | Vyvgart Hytrulo | $26 |
| ACADIA Pharmaceuticals | Meals · 2025-08-12 | Nuplazid | $24 |
| SK Life Science | Meals · 2025-08-12 | None | $20 |
| Mallinckrodt Hospital Products | Meals · 2025-08-08 | Acthar | $27 |
| Axsome Therapeutics | Meals · 2025-08-08 | Symbravo | $23 |
| Eisai | Meals · 2025-08-06 | Leqembi | $28 |
| Abbvie | Meals · 2025-08-05 | Qulipta | $26 |
| Neurelis | Meals · 2025-08-05 | Valtoco | $41 |
| Teva Pharmaceuticals USA | Meals · 2025-07-31 | Austedo Xr | $35 |
| Neurocrine BioSciences | Meals · 2025-07-17 | Ingrezza | $29 |
| Pfizer | Meals · 2025-07-16 | Nurtec Odt | $21 |
| SK Life Science | Meals · 2025-07-14 | None | $34 |
| Mallinckrodt Hospital Products | Meals · 2025-07-11 | Acthar | $19 |
| CSL Behring | Meals · 2025-07-11 | Hizentra | $28 |
| SK Life Science | Meals · 2025-07-10 | None | $10 |
| Lundbeck | Meals · 2025-07-08 | Vyepti | $15 |
| Abbvie | Meals · 2025-07-02 | Botox | $26 |
| Biogen | Meals · 2025-07-02 | Skyclarys | $23 |
| Mallinckrodt Hospital Products | Meals · 2025-07-01 | Acthar | $26 |
| Abbvie | Meals · 2025-06-27 | Qulipta | $8 |
| Lundbeck | Meals · 2025-06-27 | Vyepti | $8 |
| Merz Pharmaceuticals | Meals · 2025-06-26 | Xeomin | $30 |
| Ipsen Biopharmaceuticals | Meals · 2025-06-25 | Dysport | $23 |
| Pfizer | Meals · 2025-06-23 | Nurtec Odt | $27 |
| Teva Pharmaceuticals USA | Meals · 2025-06-18 | Austedo Xr | $39 |
| Abbvie | Paid to speak or teach · 2025-06-17 | Ubrelvy | $1,575 |
| Abbvie | Paid to speak or teach · 2025-06-17 | Qulipta | $2,625 |
| Alexion Pharmaceuticals | Meals · 2025-06-17 | Ultomiris | $30 |
| BridgeBio Pharma | Meals · 2025-06-13 | Attruby | $32 |
| Otsuka America Pharmaceutical | Meals · 2025-06-11 | Rexulti | $26 |
| SK Life Science | Meals · 2025-06-11 | None | $32 |
| Amneal Pharmaceuticals | Meals · 2025-06-06 | Rytary | $29 |
| Eisai | Meals · 2025-06-02 | Leqembi | $20 |
| Lundbeck | Meals · 2025-05-29 | Vyepti | $28 |
| Abbvie | Meals · 2025-05-28 | Qulipta | $28 |
| Janssen Biotech | Meals · 2025-05-27 | None | $40 |
| CSL Behring | Meals · 2025-05-16 | Hizentra | $26 |
| Lilly USA | Meals · 2025-05-15 | Kisunla | $26 |
| Abbvie | Meals · 2025-05-14 | Qulipta | $25 |
| Teva Pharmaceuticals USA | Meals · 2025-05-09 | Austedo Xr | $21 |
| Alexion Pharmaceuticals | Meals · 2025-05-06 | Ultomiris | $31 |
| SK Life Science | Meals · 2025-05-02 | None | $31 |
| Teva Pharmaceuticals USA | Meals · 2025-05-01 | Austedo Xr | $29 |
| Biogen | Meals · 2025-04-30 | Skyclarys | $29 |
| Eisai | Meals · 2025-04-30 | Leqembi | $22 |
| Lundbeck | Meals · 2025-04-28 | Vyepti | $18 |
| Merz Pharmaceuticals | Meals · 2025-04-25 | Xeomin | $37 |
| SK Life Science | Meals · 2025-04-25 | None | $1 |
| SK Life Science | Meals · 2025-04-25 | None | $7 |
| Pfizer | Meals · 2025-04-24 | Nurtec Odt | $25 |
| ACADIA Pharmaceuticals | Meals · 2025-04-22 | Nuplazid | $30 |
| Boston Scientific | Meals · 2025-04-21 | General - Dbs | $134 |
| Teva Pharmaceuticals USA | Meals · 2025-04-16 | Austedo Xr | $35 |
| Otsuka America Pharmaceutical | Meals · 2025-04-15 | Rexulti | $19 |
| Amneal Pharmaceuticals | Meals · 2025-04-11 | Rytary | $26 |
| Neurocrine BioSciences | Meals · 2025-04-10 | Ingrezza | $30 |
| Lundbeck | Meals · 2025-04-09 | Vyepti | $8 |
| SK Life Science | Meals · 2025-04-08 | None | $26 |
| Neurelis | Meals · 2025-04-07 | Valtoco | $24 |
| Abbvie | Meals · 2025-04-04 | Qulipta | $3 |
| Abbvie | Meals · 2025-04-04 | Botox | $19 |
| Biogen | Meals · 2025-04-04 | Vumerity | $27 |
| Lilly USA | Meals · 2025-04-03 | Kisunla | $32 |
| SK Life Science | Meals · 2025-04-03 | None | $8 |
| Octapharma USA | Meals · 2025-04-01 | Panzyga | $35 |
| Pfizer | Meals · 2025-03-31 | Nurtec Odt | $19 |
| Ucb | Meals · 2025-03-28 | Briviact | $18 |
| Abbvie | Meals · 2025-03-27 | Ubrelvy | $7 |
| Noctrix Health | Meals · 2025-03-27 | Nidra | $349 |
| Eisai | Meals · 2025-03-26 | Leqembi | $22 |
| Argenx US | Meals · 2025-03-25 | Vyvgart Hytrulo | $24 |
| Alexion Pharmaceuticals | Meals · 2025-03-24 | Ultomiris | $29 |
| MDD US Operations | Meals · 2025-03-21 | None | $34 |
| Teva Pharmaceuticals USA | Education · 2025-03-19 | None | $78 |
| Teva Pharmaceuticals USA | Meals · 2025-03-19 | Austedo Xr | $26 |
| Lundbeck | Meals · 2025-03-19 | Vyepti | $32 |
| Abbvie | Paid to speak or teach · 2025-03-18 | Ubrelvy | $1,575 |
| SK Life Science | Meals · 2025-03-18 | None | $9 |
| EMD Serono | Meals · 2025-03-17 | None | $21 |
| Abbvie | Meals · 2025-03-12 | Ubrelvy | $21 |
| Abbvie | Meals · 2025-03-06 | Qulipta | $8 |
| Amneal Pharmaceuticals | Meals · 2025-03-06 | Rytary | $23 |
| SK Life Science | Meals · 2025-03-06 | None | $9 |
| Abbvie | Meals · 2025-03-05 | Botox | $20 |
| Otsuka America Pharmaceutical | Meals · 2025-03-04 | Rexulti | $20 |
| Grifols USA | Meals · 2025-03-03 | Gamunex-C | $27 |
| Amgen | Meals · 2025-02-27 | Uplizna | $24 |
| Neurelis | Meals · 2025-02-26 | Valtoco | $17 |
| Lilly USA | Meals · 2025-02-25 | Kisunla | $22 |
| Alexion Pharmaceuticals | Meals · 2025-02-24 | Ultomiris | $25 |
| Alexion Pharmaceuticals | Meals · 2025-02-24 | Ultomiris | $2 |
| Ucb | Meals · 2025-02-21 | Rystiggo | $25 |
| SK Life Science | Meals · 2025-02-21 | None | $34 |
| Eisai | Meals · 2025-02-19 | Leqembi | $32 |
| Abbvie | Meals · 2025-02-18 | Botox | $28 |
| Pfizer | Meals · 2025-02-17 | Nurtec Odt | $28 |
| Lundbeck | Meals · 2025-02-12 | Vyepti | $24 |
| Impel Pharmaceuticals | Meals · 2025-02-11 | Trudhesa | $18 |
| Teva Pharmaceuticals USA | Meals · 2025-02-06 | Austedo Xr | $31 |
| ANI Pharmaceuticals | Meals · 2025-02-05 | Purified Cortrophin Gel | $29 |
| SK Life Science | Meals · 2025-01-28 | None | $19 |
| Abbvie | Meals · 2025-01-24 | Botox | $28 |
| Abbvie | Meals · 2025-01-24 | Qulipta | $60 |
| Pfizer | Meals · 2025-01-24 | Nurtec Odt | $15 |
| Abbvie | Meals · 2025-01-23 | Qulipta | $24 |
| SK Life Science | Meals · 2025-01-20 | None | $21 |
| SK Life Science | Meals · 2025-01-20 | None | $3 |
| Biogen | Meals · 2025-01-16 | Skyclarys | $30 |
| Lundbeck | Meals · 2025-01-16 | Vyepti | $12 |
| Lundbeck | Meals · 2025-01-16 | Vyepti | $1 |
| Lundbeck | Meals · 2025-01-16 | Vyepti | $2 |
| EMD Serono | Meals · 2025-01-14 | None | $29 |
| Biogen | Meals · 2025-01-09 | Skyclarys | $29 |
| Teva Pharmaceuticals USA | Meals · 2025-01-09 | Austedo Xr | $24 |
| Ucb | Meals · 2025-01-06 | Briviact | $20 |
| SK Life Science | Meals · 2025-01-03 | None | $23 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $17,805
| Abbvie | Qulipta | $14,365 | 32 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $462 | 16 payments
|
| SK Life Science | None | $314 | 14 payments
|
| Alexion Pharmaceuticals | Ultomiris | $259 | 10 payments
|
| Neurocrine Biosciences | Ingrezza | $251 | 7 payments
|
| Biogen | Tysabri | $215 | 9 payments
|
| Jazz Pharmaceuticals | Epidiolex | $145 | 7 payments
|
| Boston Scientific | Wavewriter Alpha Prime 16 | $143 | 2 payments
|
| Pfizer | Nurtec Odt | $138 | 6 payments
|
| Argenx US | Vyvgart Hytrulo | $132 | 5 payments
|
| Lilly USA | Amyvid | $123 | 5 payments
|
| Neurelis | Valtoco | $105 | 3 payments
|
| Eisai | Leqembi | $105 | 4 payments
|
| Corium | Azstarys | $99 | 4 payments
|
| Genentech USA | Ocrevus | $97 | 4 payments
|
| Lundbeck | Vyepti | $93 | 3 payments
|
| Celgene | Zeposia | $91 | 4 payments
|
| Kyowa Kirin | Nourianz | $83 | 3 payments
|
| Otsuka America Pharmaceutical | Nuedexta | $70 | 3 payments
|
| Ucb | Briviact | $70 | 3 payments
|
| Acorda Therapeutics | Inbrija | $67 | 3 payments
|
| Octapharma USA | Panzyga | $60 | 2 payments
|
| EMD Serono | None | $58 | 2 payments
|
| Sumitomo Pharma America | Aptiom | $53 | 2 payments
|
| Tris Pharma | Dyanavel Xr | $43 | 2 payments
|
| MDD US Operations | Gocovri | $27 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $26 | 1 payment
|
| Banner Life Sciences | Bafiertam | $25 | 1 payment
|
| Ironshore Pharmaceuticals | Jornay Pm | $24 | 1 payment
|
| Life Molecular Imaging | Neuraceq | $22 | 1 payment
|
| Averitas Pharma | Qutenza | $21 | 1 payment
|
| Azurity Pharmaceuticals | None | $20 | 1 payment
|
2023: $15,189
| Abbvie | Qulipta | $11,408 | 38 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $439 | 16 payments
|
| Impel Pharmaceuticals | Trudhesa | $339 | 28 payments
|
| Jazz Pharmaceuticals | Epidiolex | $332 | 12 payments
|
| Sumitomo Pharma America | Aptiom | $273 | 13 payments
|
| SK Life Science | None | $236 | 10 payments
|
| Neurocrine Biosciences | Ingrezza | $215 | 7 payments
|
| Celgene | Zeposia | $201 | 18 payments
|
| Alexion Pharmaceuticals | Ultomiris | $186 | 6 payments
|
| Biogen | Tysabri | $176 | 8 payments
|
| Argenx US | Vyvgart | $168 | 5 payments
|
| Ucb | Briviact | $147 | 6 payments
|
| Acorda Therapeutics | Inbrija | $141 | 6 payments
|
| Otsuka America Pharmaceutical | Nuedexta | $135 | 8 payments
|
| Pfizer | Nurtec Odt | $135 | 6 payments
|
| Lilly USA | Emgality | $109 | 6 payments
|
| MDD US Operations | None | $100 | 5 payments
|
| Neurelis | Valtoco | $67 | 2 payments
|
| ACADIA Pharmaceuticals | Daybue | $50 | 2 payments
|
| Amgen | Aimovig | $48 | 2 payments
|
| Amneal Pharmaceuticals | Rytary | $47 | 2 payments
|
| Lundbeck | Vyepti | $45 | 2 payments
|
| Life Molecular Imaging | Neuraceq | $33 | 1 payment
|
| Averitas Pharma | Qutenza | $30 | 1 payment
|
| Genentech USA | Ocrevus | $29 | 1 payment
|
| Banner Life Sciences | Bafiertam | $27 | 1 payment
|
| Neuropace | Rns Neurostimulator Kit | $26 | 1 payment
|
| ANI Pharmaceuticals | Purified Cortrophin Gel | $24 | 1 payment
|
| Kyowa Kirin | Nourianz | $22 | 1 payment
|
2022: $38,689
| Abbvie | Ubrelvy | $27,484 | 62 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $5,386 | 32 payments
|
| Teva Pharmaceuticals USA | Ajovy | $1,342 | 16 payments
|
| Amgen | Aimovig | $718 | 7 payments
|
| Impel Pharmaceuticals | Trudhesa | $368 | 21 payments
|
| Boston Scientific | General - Dbs | $278 | 3 payments
|
| SK Life Science | None | $272 | 10 payments
|
| Ucb | Briviact | $262 | 8 payments
|
| Avanir Pharmaceuticals | Nuedexta | $262 | 16 payments
|
| Celgene | Zeposia | $224 | 12 payments
|
| Sunovion Pharmaceuticals | Aptiom | $223 | 10 payments
|
| Jazz Pharmaceuticals | Epidiolex | $223 | 12 payments
|
| Neurocrine Biosciences | Ingrezza | $199 | 7 payments
|
| Janssen Pharmaceuticals | Ponvory | $166 | 6 payments
|
| Lilly USA | Emgality | $143 | 8 payments
|
| Alexion Pharmaceuticals | Ultomiris | $137 | 7 payments
|
| GRT US Holding | Qutenza | $122 | 4 payments
|
| Acorda Therapeutics | Inbrija | $106 | 5 payments
|
| Biogen | Tysabri | $102 | 5 payments
|
| Ironshore Pharmaceuticals | Jornay Pm | $91 | 4 payments
|
| GE HealthCare | None | $84 | 2 payments
|
| Banner Life Sciences | Bafiertam | $77 | 4 payments
|
| Exeltis USA | Purified Cortrophin Gel | $68 | 3 payments
|
| Allergan | Botox | $52 | 2 payments
|
| MDD US Operations | None | $46 | 2 payments
|
| Lundbeck | Vyepti | $46 | 2 payments
|
| Kyowa Kirin | Nourianz | $44 | 2 payments
|
| Supernus Pharmaceuticals | Trokendi Xr | $38 | 2 payments
|
| Avion Pharmaceuticals | Dhivy | $37 | 2 payments
|
| Nevro | Omnia | $24 | 1 payment
|
| ACADIA Pharmaceuticals | Nuplazid | $20 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $20 | 1 payment
|
| Ultragenyx Pharmaceutical | None | $20 | 1 payment
|
2021: $53,424
| AbbVie | Ubrelvy | $28,702 | 36 payments
|
| Teva Pharmaceuticals USA | Ajovy | $12,967 | 30 payments
|
| Allergan | Botox | $8,045 | 12 payments
|
| Amgen | Aimovig | $696 | 11 payments
|
| Ucb | Briviact | $364 | 17 payments
|
| Biohaven Pharmaceuticals | Nurtec Odt | $359 | 35 payments
|
| SK Life Science | Xcopri | $267 | 14 payments
|
| Avanir Pharmaceuticals | Nuedexta | $243 | 13 payments
|
| Boston Scientific | General Dbs | $208 | 4 payments
|
| Neurocrine Biosciences | Ingrezza | $181 | 10 payments
|
| Greenwich Biosciences | Epidiolex | $179 | 8 payments
|
| Lilly USA | Emgality | $156 | 7 payments
|
| Alexion Pharmaceuticals | Soliris | $136 | 8 payments
|
| Horizon Therapeutics plc | Uplizna | $101 | 3 payments
|
| Biogen | Tysabri | $92 | 4 payments
|
| Celgene | Zeposia | $87 | 5 payments
|
| Adamas Pharmaceuticals | Gocovri | $85 | 4 payments
|
| Upsher-Smith Laboratories | Tosymra | $57 | 3 payments
|
| Kyowa Kirin | Nourianz | $56 | 3 payments
|
| Mallinckrodt Hospital Products | Acthar | $53 | 2 payments
|
| Sunovion Pharmaceuticals | Kynmobi | $53 | 4 payments
|
| Neurelis | Valtoco | $48 | 2 payments
|
| Lundbeck | Vyepti | $46 | 2 payments
|
| Janssen Pharmaceuticals | None | $44 | 2 payments
|
| Ge Healthcare | None | $40 | 2 payments
|
| Medtronic | Percept | $33 | 1 payment
|
| Catalyst Pharmaceuticals | Firdapse | $23 | 1 payment
|
| Arbor Pharmaceuticals | Horizant | $22 | 1 payment
|
| Novartis Pharmaceuticals | Kesimpta | $22 | 1 payment
|
| Acorda Therapeutics | Inbrija | $20 | 1 payment
|
| Xeris Pharmaceuticals | Keveyis | $16 | 1 payment
|
| Supernus Pharmaceuticals | Qelbree | $12 | 1 payment
|
| ACADIA Pharmaceuticals | Nuplazid | $12 | 1 payment
|
2020: $49,895
| Teva Pharmaceuticals USA | Ajovy | $25,046 | 38 payments
|
| Allergan | Ubrelvy | $22,254 | 35 payments
|
| Amgen | Aimovig | $464 | 10 payments
|
| Avanir Pharmaceuticals | Nuedexta | $278 | 14 payments
|
| Ucb | Briviact | $250 | 10 payments
|
| SK Life Science | Cenobamate | $239 | 10 payments
|
| Alexion Pharmaceuticals | Soliris | $237 | 14 payments
|
| Neurocrine Biosciences | Ingrezza | $194 | 9 payments
|
| US WorldMeds | Xadago | $184 | 10 payments
|
| ACADIA Pharmaceuticals | Nuplazid | $129 | 7 payments
|
| Adamas Pharmaceuticals | Gocovri | $114 | 8 payments
|
| Greenwich Biosciences | Epidiolex | $83 | 4 payments
|
| Mallinckrodt Hospital Products | Acthar | $78 | 4 payments
|
| Arbor Pharmaceuticals | Horizant | $56 | 3 payments
|
| Boston Scientific | General - Dbs | $45 | 2 payments
|
| Zyla Life Sciences | Sprix | $39 | 2 payments
|
| Kyowa Kirin | Nourianz | $35 | 2 payments
|
| Lilly USA | Emgality | $32 | 2 payments
|
| Novartis Pharmaceuticals | Kesimpta | $24 | 1 payment
|
| Integra LifeSciences | Codman Certas | $23 | 1 payment
|
| Ge Healthcare | None | $23 | 1 payment
|
| Ironshore Pharmaceuticals | Jornay Pm | $19 | 1 payment
|
| Biohaven Pharmaceuticals | Nurtec Odt | $19 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Zeposia | $15 | 1 payment
|
| Supernus Pharmaceuticals | Trokendi Xr | $14 | 1 payment
|
2019: $67,691
| Teva Pharmaceuticals USA | Ajovy | $41,541 | 70 payments
|
| Amgen | Aimovig | $18,292 | 39 payments
|
| Amneal Pharmaceuticals | Rytary | $3,482 | 5 payments
|
| Avanir Pharmaceuticals | Nuedexta | $1,137 | 26 payments
|
| Ucb | Briviact | $398 | 16 payments
|
| Greenwich Biosciences | Epidiolex | $334 | 12 payments
|
| Mallinckrodt Enterprises | Acthar | $295 | 14 payments
|
| US WorldMeds | Xadago | $262 | 17 payments
|
| Alexion Pharmaceuticals | Soliris | $194 | 17 payments
|
| Biogen | Tysabri | $193 | 3 payments
|
| ACADIA Pharmaceuticals | Nuplazid | $170 | 14 payments
|
| Bausch Health US | Migranal | $161 | 11 payments
|
| Lilly USA | Emgality | $139 | 14 payments
|
| Boston Scientific | General Dbs | $134 | 2 payments
|
| Allergan | Botox | $119 | 9 payments
|
| Adamas Pharmaceuticals | Gocovri | $70 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Vyvanse | $62 | 4 payments
|
| Lundbeck | Northera | $59 | 3 payments
|
| Novartis Pharmaceuticals | Mayzent | $58 | 3 payments
|
| EMD Serono | Mavenclad | $52 | 2 payments
|
| Zyla Life Sciences | Sprix | $49 | 2 payments
|
| Pfizer | Lyrica | $41 | 3 payments
|
| Arbor Pharmaceuticals | Horizant | $39 | 2 payments
|
| Vertical Pharmaceuticals | Osmolex Er | $37 | 2 payments
|
| Genentech USA | Ocrevus | $36 | 2 payments
|
| Acorda Therapeutics | Inbrija | $36 | 2 payments
|
| Abbott Laboratories | Infinity Dbs Pulse Generators | $36 | 2 payments
|
| CSL Behring | Hizentra | $36 | 2 payments
|
| Shire North American Group | Vyvanse | $35 | 2 payments
|
| Assertio Therapeutics | Cambia | $33 | 2 payments
|
| Neos Therapeutics LP | Adzenys Xr-Odt | $31 | 1 payment
|
| Supernus Pharmaceuticals | Trokendi Xr | $30 | 2 payments
|
| LivaNova USA | Vns Therapy | $21 | 1 payment
|
| AbbVie | Duopa | $19 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $18 | 1 payment
|
| Promius Pharma | Zembrace Symtouch | $17 | 1 payment
|
| Grifols USA | Gamunex-C | $16 | 1 payment
|
| Genzyme | Pompe - Disease | $12 | 1 payment
|
Checkups this office reported
18 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 87.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Appropriate Treatment for Upper Respiratory Infection (URI)As Medicare defines this measure | 100% | 38 |
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 93%That's most of the people this applied to. | 641 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 65%That's more than half. | 284 |
| Bone-density scans that were not neededYounger women who got a bone scan without a medical reason | 1%That's few of the people this applied to. Better on this measure. | 135 |
| Breast cancer screeningEligible women who got a mammogram | 40%That's less than half. | 403 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 16%That's few of the people this applied to. | 620 |
| Checked for fall riskOlder patients screened for fall risk | 57%That's more than half. | 423 |
| Chlamydia Screening for WomenAs Medicare defines this measure | 4% | 52 |
See the other 10 measures
| Colon cancer screeningEligible adults who got a colon cancer test | 24%That's few of the people this applied to. | 707 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 10%That's few of the people this applied to. | 1,230 |
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 4%That's few of the people this applied to. | 82 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 76%That's most of the people this applied to. Worse on this measure. | 82 |
| HIV screeningEligible patients who were screened for HIV | 17%That's few of the people this applied to. | 1,098 |
| Medications listed in the chartVisits where the current medication list was documented | 97%That's most of the people this applied to. | 2,431 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 94%That's most of the people this applied to. | 624 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 100%That's most of the people this applied to. | 1,787 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 70%That's more than half. | 364 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 43%That's less than half. | 1,382 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Checks the state prescription-drug database before prescribing
- Did a security review of patient data
- Exchanges records both ways with other health systems
- Improved the patient portal
- Lets patients read their visit notes
- Reports cases to public health electronically
- Shows lab and imaging costs when ordering tests
- Uses standard treatment protocols
- Exempt from immunization registry reporting
Professional record
- NPI
- 1235326232
- Licence
- CA 20A11843
- Group
- Bass Medical Group
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 18431 Technology Dr, Morgan Hill, CA, 95037
- NPI first listed
- 2007-10-03
- NPI last updated
- 2025-03-04
- NPI record certified
- 2025-03-04
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 16130 Juan Hernandez Dr, Morgan Hill, CA, 95037